The Food and Drug Administration faces major leadership instability following the firing of Tracy Beth Hoeg and the departure of several senior officials.These changes occur after the recent resignation of Marty Makary, leaving the agency without permanent leadership across key regulatory divisions.Newly appointed officials are now tasked with managing intense criticism regarding vaccine safety policies and internal governance.